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Abstract
Background: It has been suggested that low μM concentrations of S-nitrosoglutathione (GSNO),
an endogenous bronchodilator, may promote maturation of the defective cystic fibrosis (CF)
transmembrane conductance regulator (CFTR). Because nitric oxide (NO) and GSNO levels
appear to be low in the CF airway, there is an interest in the possibility that GSNO replacement
could be of therapeutic benefit in CF.
Methods: The effect of GSNO on chloride (Cl-) transport was investigated in primary nasal
epithelial cells obtained from CF patients homozygous for the delF508 mutation, as well as in two
CF cell lines (CFBE and CFSME), using both a fluorescent Cl- indicator and X-ray microanalysis.
Maturation of delF508 CFTR was determined by immunoblotting.
Results: Treatment with 60 μM GSNO for 4 hours increased cAMP-induced chloride efflux in
nasal epithelial cells from 18 out of 21 CF patients, but did not significantly affect Cl- efflux in cells
from healthy controls. This Cl- efflux was confirmed by measurements with a fluorescent Cl-
indicator in the CFBE and CFSME cell lines. The effect of GSNO on Cl- efflux in CFBE cells could
be inhibited both by a specific thiazolidinone CFTR inhibitor (CFTRinh-172) and by 4,4'-
diisothiocyanatodihydrostilbene-2,2'-disulfonic acid (H2DIDS). X-ray microanalysis showed that,
following 4 hours incubation with 60 μM GSNO, cAMP agonists caused a decrease in the cellular
Cl- concentration in CFBE cells, corresponding to Cl- efflux. GSNO exposure resulted in an
increase in the protein expression and maturation, as shown by immunoblot analysis. GSNO did
not increase the cytosolic Ca2+ concentration in cultured airway epithelial cells.
Conclusion: Previous studies have suggested that treatment with GSNO promotes maturation of
delF508-CFTR, consistent with our results in this study. Here we show that GSNO increases
chloride efflux, both in the two CF cell lines and in primary nasal epithelial cells from delF508-CF
patients. This effect is at least in part mediated by CFTR. GSNO may be a candidate for
pharmacological treatment of the defective chloride transport in CF epithelial cells.
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Background
Cystic Fibrosis (CF) is a common life-shortening inherited
disorder [1]. The disease is caused by mutations in the
gene for the cystic fibrosis transmembrane conductance
regulator (CFTR), a cAMP-regulated chloride channel
present in the apical membrane of epithelia in many
organs, including airways [2].
CFTR is synthesized in the endoplasmic reticulum (ER)
and transported to the Golgi complex where, after N-glyc-
osylation, it becomes a mature protein that via the secre-
tory pathway reaches the plasma membrane. The folding
of CFTR occurs by complex interactions between newly
synthesized CFTR and chaperones such as heat shock cog-
nate (Hsc) 70 and, later, the ER chaperones calnexin and
heat shock protein (Hsp70) [3-5]. The processing of CFTR
in the ER is an inefficient process followed by rapid degra-
dation of about 75% of nascent wild type CFTR. The high
rate of degradation is believed to be an intrinsic property
of CFTR [6]. Recently, Yoo et al. [7] reported an alternative
pathway of CFTR trafficking between ER and Golgi com-
plex that may also affect CFTR expression in the cell mem-
brane.
The most common CFTR mutation in the CF population,
delF508, leads to the expression of a protein with a miss-
ing phenylalanine residue at the 508 position in the
nucleotide binding domain 1 (NBD 1) [2]. Deletion of
F508 interferes with proper folding and trafficking of
CFTR-delF508 from ER to the cell surface [8]. However, if
CFTR-delF508 reaches the cell membrane, it is able to
mediate partial Cl- conductance even though the channel
exhibits altered kinetics [9]. This suggests a possible ther-
apeutic strategy for CF treatment based on increasing the
efficiency of folding and intracellular processing of this
mutant [9,10].
The endogenous bronchodilator, S-nitrosoglutathione
(GSNO) has been proposed as a possible pharmacologi-
cal remedy that reverses the CFTR-ΔF508 maturation
defect as detected by immunoblot [11], causes a 4-fold
increase in CFTR-mediated chloride efflux and promotes
apical location of CFTR in cultured CF airway epithelial
cells [12]. Preliminary evidence suggests that GSNO can
affect CFTR expression and maturation through several
mechanisms, including 1) a transcriptional effect involv-
ing specificity protein (Sp)3 [11]; and 2) post-transla-
tional effects mediated by an effect on cysteine string
protein expression, on heat shock cognate 70 S-nitrosyla-
tion [13] and other effects. However, the effect of GSNO
on native cells taken from CF patients or primary cell cul-
tures has not yet been investigated; and pharmacological
evidence that the Cl- efflux measured involves CFTR has
been incomplete. Further, high μM levels of GSNO could
have adverse effects on CFTR of inhibiting its transcrip-
tion, augmenting its degradation and inhibiting its func-
tion. Therefore, it is important to determine the precise
effect of GSNO on airway cells taken directly from CF
patients. Here, we show that GSNO increases maturation
and function of delF508 CFTR using both airway epithe-
lial cell lines and primary nasal epithelial cells from CF
patients.
Methods
Individuals and genotypes
Nasal epithelial cells were obtained by brush biopsy from
patients with CF homozygous for the delF508 mutation
(n = 21) and healthy volunteers with no clinical signs of
CF (n = 8). Genotypes of the patients participating in the
study were determined by established DNA molecular
techniques[14]. The study was approved by the Ethical
Committee of Karolinska University Hospital and the par-
ticipants had given informed consent.
Obtaining nasal cells by brush biopsy
Nasal brushing was performed as described elsewhere
[15]. Briefly, an interdental brush with 2.5 or 3.0 mm bris-
tles (Apoteket AB, Stockholm, Sweden) was used to scrape
along the inferior nasal turbinate and lateral nasal wall.
Brushes with cells were immediately placed into 1.5 ml of
Eagle's minimal essential medium (EMEM) with
Glutamax (SVA, Uppsala, Sweden) supplemented with
10% fetal bovine serum, 100 U/ml penicillin, and 100 μg/
ml streptomycin sulfate at room temperature. When cells
needed to be transported to the laboratory the tube was
kept at 4°C for no longer than 3 hours. Cells were
removed from the brush by passing it up and down
through a disposable P200 pipette tip (Treff, Degersheim,
Switzerland) with the end of the tip cut off. Cells were
kept at 37°C in a 5% CO2-humidified incubator over-
night.
Chemicals and solutions
The fluorescent probe N-(ethoxycarbonylmethyl)-6-
methoxyquinolinium bromide (MQAE) nigericin and
4,4'-diisothiocyanatodihydrostilbene-2,2'-disulfonic acid
disodium salt hydrate (H2DIDS) were obtained from
Molecular Probes (Eugene, OR, U.S.A); tributyltin acetate
from Aldrich-Chemie (Steinheim, Germany); the NO-
donor GEA3162 (5-amino-3-(3,4-dichlorophe-
nyl)1,2,3,4-oxatriazolium) (Moilanen et al., 1993) was
from Alexis Biochemicals (San Diego, CA, USA); forsko-
lin, 3-isobutyl-1-methylxantine (IBMX), and ATP were
from Sigma (St Louis, MO, U.S.A). Thiazolidinone CFTR
inhibitor (CFTRinh-172) was a generous gift of Prof. A.
Verkman, San Francisco, CA, U.S.A.
Standard Ringer's solution (SR) consisted of: 140 mM
NaCl, 5 mM KCl, 5 mM (2-hydroxyethyl)-N-piperazine
N-2 ethanesulphonic acid (HEPES), 1 mM MgCl2 and 5Respiratory Research 2006, 7:124 http://respiratory-research.com/content/7/1/124
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mM glucose, pH 7.4. In chloride-free Standard Ringer's
solution the chloride salts were exchanged for nitrate salts.
K+-rich calibration buffers were made by mixing of 150
mM chloride solution (120 mM KCl, 1 mM MgCl2, 27
mM NaCl, 5 mM glucose and 5 mM HEPES), and 150 mM
NO3 
- solutions (chloride exchanged for nitrate) to obtain
the desired concentrations of chloride.
Cell culture
The CFBE41o- CF bronchial epithelial (homozygous for
the delF508 mutation) and the CFSMEo- CF submucosal
gland epithelial (delF508/2QX) cell lines, generous gifts
from Dr. D. Gruenert, San Francisco, CA, U.S.A., were cul-
tured in EMEM with Glutamax (SVA) supplemented with
10% fetal bovine serum (Gibco, Paisley, U.K.), 100 U/ml
penicillin, and 100 μg/ml streptomycin sulfate at 37°C in
a 5% CO2-humidified incubator. The medium was
changed twice weekly.
Intracellular chloride measurements
Nasal epithelial cells were made to attach to glass cover
slips by treating slides with BD Cell-Tak (BD Bioscience,
Bedford, MA, U.S.A). CFBE and CFSME cells were grown
to confluence on glass cover slips. Prior to Cl- efflux meas-
urements, the cell lines and the nasal epithelial cells were
treated with 60 μM GSNO for a total of 4 hours at 37°C.
The treatment was performed by adding freshly made
GSNO solution every 30 minutes, by exchanging the incu-
bation solution. The cells were loaded with 10 mM MQAE
for 2 h, rinsed in SR solution and the cover slips were
placed as bottom in a perfusion chamber on the stage of
an inverted microscope (Nikon, Diaphot, Japan). The
temperature was kept at 37°C by heating the chamber
holder and the objective separately. A 75 W xenon lamp
and a monochromator, part of a Quanticell 2000 image-
processing system (VisiTech International, Sunderland,
U.K.), provided excitation light at 355 nm (12 nm band-
width). The emission was measured at 460 nm (30 nm
bandwidth) using a CCD camera. Cells were bathed in SR.
Images were captured for 16 ms every 3–8 seconds as
described elsewhere [16].
The basal Cl- efflux was measured during the exposure of
cells loaded with MQAE to a chloride gradient. Chloride
efflux was induced by changing from 150 mM chloride
buffer to a chloride-free buffer with NO3 
- as the substitut-
ing anion without stimulating agents. The basal efflux was
compared to that obtained in the presence of cAMP ago-
nists (20 μM forskolin and 50 μM IBMX) under similar
conditions. The agonists or blockers were added 1 min
before the change of buffer.
For the nasal epithelial cells, the fluorescence was
expressed as relative change (Frel) in fluorescence (F) to
the initial fluorescence at the beginning of the experiment
(F0) according to
Frel = F/F0 × 100 (%)   (1)
The relative chloride efflux rate (JCl-) was determined from
the first derivative of Frel with time (ΔFrel/Δt), percent/s.
The efflux via CFTR was determined by subtracting the
basal relative efflux (Jbasal) from the cAMP-stimulated rel-
ative rate (JcAMP), according to:
JCFTR = JcAMP - J basal   (2)
The chloride measurements on nasal epithelial cells
obtained from healthy individuals were performed on the
day when the biopsy had been taken (day 0). The nasal
cells from CF patients were kept overnight in the incuba-
tor in order to perform the 4 h GSNO incubation along
with chloride measurements during the same day. There-
fore, chloride studies were conducted on the next day (day
1). To verify compatibility of the results, the chloride
efflux was measured on day 0 and day 1 on the cells from
healthy volunteers and values obtained were not signifi-
cantly different (data not shown). The chloride efflux
from CFBE and CFSME cells was determined quantita-
tively as described previously [12].
For each experiment, all the cells in the optical field were
analyzed (15–30 cells) and the average response was
counted as one experimental data point. GraphPad Prism
4.0 software (GraphPad Software, San Diego, CA, U.S.A)
was used to determine the value of the Cl- efflux rate.
Intracellular calcium measurements
Cells were grown on glass slides until confluence and
loaded with the calcium-sensitive dye fura2-AM (Molecu-
lar Probes), 1–5 μM in standard Ringer's solution, for 45
min at 37°C. The cells were mounted as described above
and excited by alternating 340 and 380 nm light using a
filter changer under the control of In CytIm-2 software
(Intracellular Imaging Corp., Cincinnati, OH, U.S.A) and
a 430 nm dichroic mirror. The emission was measured
through a 510 nm barrier filter with an integrating CCD
camera (Cohu, Inc., San Diego, CA, U.S.A). A new
rationed image (340 nm/380 nm) was obtained every sec-
ond and the intracellular calcium concentration was cal-
culated [17].
X-ray microanalysis
CFBE and CFSME cells were grown to confluence on tita-
nium grids covered with a carbon coated Formvar film
(Merck, Darmstadt, Germany). The cells were rinsed in SR
and the grid put in a 20 μl drop of SR (control) or chlo-
ride-free SR with 20 μM forskolin + 50 μM IBMX for 3
min. The cells were rinsed with cold distilled water forRespiratory Research 2006, 7:124 http://respiratory-research.com/content/7/1/124
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some seconds before they were frozen in liquid propane
cooled by liquid nitrogen (-180°C) and freeze-dried over-
night in vacuum at -150°C. The freeze-dried cells were
covered with a conductive carbon layer before analysis.
Analysis was performed in a Hitachi (Tokyo, Japan)
H7100 electron microscope in the scanning-transmission
electron microscopy (STEM) mode at 100 kV with an
Oxford Instruments (Oxford, U.K.) ISIS energy-dispersive
spectrometer system. Quantitative analysis was performed
by comparing the ratio of the characteristic peak and the
background under the peak (P/B) with the P/B ratios from
standards consisting of a gelatin/glycerol matrix with min-
eral salts in known concentrations [18]. Spectra were
acquired for 50 seconds and each cell was analyzed only
once. The data were standardized, using the peak for
phosphorus, to correct for variations in the extraneous
background. A minimum of 30 cells/experiment was
measured.
Immunoblot analysis
CFBE cells were seeded at 0.5–1 × 106 cells/cm2 and grown
on 0.4 μm pore filters (Transwell, Corning, NY) at air-liq-
uid interface. Immunoblot was performed as previously
described (Zaman et al, 2001, 2004, 2006). Briefly, whole
cell extracts were prepared in 1% Nonidet P40 (Sigma)
lysis buffer containing 50 mM Tris-HCl (pH 8.0), 150 mM
NaCl, 2 mM leupeptin, 1 mM aprotinin and 1 mM pep-
stain, 1 mM PMSF and 2 mM Na2VO4 (Boehringer Man-
nheim, Indianapolis, IN) were sheared through a 25-
gauge needle, fractioned on a 6% SDS polyacrylamide gel
in 1x electrode buffer (25 mM Tris, 192 mM glycine, 0.1%
SDS at pH 8.3), transferred to nitrocellulose membranes
(Bio-Rad, Hercules, CA) in Tobin Transfer Buffer (25 mM
Tris, 192 mM glycine, 20% methanol, pH 8.3), blocked in
Tris buffered saline-Tween 20 (TBS-T = 10 mM Tris-HCl,
150 mM NaCl, 0.05% Tween 20, 5% nonfat dried milk at
pH 8.0) and probed (1 hr, RT) with 1:1000 with anti-
CFTR monoclonal Ab 596 (kindly provided by Dr. J. R.
Riordan, Scottsdale, AZ, USA) Blots were washed, incu-
bated (30 min) with 1:2000 HRP-conjugated anti-mouse
antibody (Pierce, Rockford, IL) in TBS-T (30 min) and vis-
ualized using Hyperfilm (Amersham Pharmacia Biotech).
Per line 50 mg of protein was loaded.
Statistical analysis
Data are shown as mean ± standard error of mean (SEM).
Where appropriate a paired Student's t test or analysis of
variance (ANOVA followed by Bonferroni test) was used
to estimate the difference between treated and untreated
groups. A probability value p < 0.05 was considered signif-
icant.
Results
GSNO increases delF508 CFTR function in primary nasal 
epithelial cells from CF patients
In the nasal tall columnar ciliated (TCC) epithelial cells
from CF patients, GSNO treatment increased the relative
cAMP-dependent efflux rate (JCFTR) from -0.19 ± 0.06 to
0.11 ± 0.08 percent/s (see Methods), reaching the efflux
level observed in healthy nasal columnar cells. Out of 21
patients, 18 demonstrated accelerated chloride efflux after
GSNO treatment and in 3 patients this parameter did not
improve (Fig. 1a, 1c). The effect of GSNO was statistically
significant (p < 0.01). Chloride efflux in nasal cells from
healthy persons was not affected by GSNO treatment (Fig.
1b, 1c).
GSNO increases ΔF508 CFTR expression and maturation 
in ΔF508 CFTR homozygous airway epithelial cell culture
Treatment with low μM concentrations of GSNO resulted
in a dose-dependent increase in the expression and matu-
ration of both bands B and C (Figure 2). However, at
higher concentration (100 μM) GSNO inhibited CFTR
expression (data not shown). This dose-dependent exper-
iments suggest that concentrations of 5 to 10 μM are opti-
mal for this effect as was shown before[11,13].
GSNO increases the chloride efflux rate in delF508 CFTR 
homozygous airway epithelial cell cultures
Chloride transport studies with the fluorescent dye MQAE
revealed that treatment with 60 μM GSNO for 4 hours
increased about 3-4-fold the cAMP-dependent efflux rate
from 0.26 ± 0.04 to 1.05 ± 0.15 mM/s in CFBE cells (Fig.
3a) and from 0.25 ± 0.06 to 0.6 ± 0.18 mM/s in CFSME
cells (Fig. 3b). After GSNO treatment, the basal efflux
increased in a similar way as the cAMP-activated Cl- efflux.
The basal efflux in CFBE cells was sensitive to 200 μM
H2DIDS (unspecific blocker of Cl- channels other than
CFTR). The cAMP-stimulated efflux in the GSNO-treated
cells was effectively blocked by 40 μM CFTRinh-172 (a spe-
cific blocker of CFTR), which is proof that the CFTR chan-
nels were actively involved in this efflux (Fig. 3a).
To further elucidate how much of the increased efflux
could be ascribed to NO-release from GSNO, the NO-
donor GEA3126 was used. In CFBE cells, treatment with
25 μM GEA3162 for 5 min increased basal Cl- efflux to 0.6
± 0.04 mM/s which represents about half the effect
obtained with GSNO. After 4 hours of GEA3162 treat-
ment Cl- efflux was 0.5 ± 0.09 mM/s, not different from
the 5 min treatment. The cAMP-mediated Cl- efflux in
these cells was 0.26 ± 0.06 mM/s, which increased to 0.4
± 0.05 mM/s after 5 min and to 0.5 ± 0.05 mM/s after 4 h
of the GEA3162 treatment (Fig. 3a).
X-ray microanalysis demonstrated that increasing the cel-
lular cAMP concentration with IBMX and forskolin hadRespiratory Research 2006, 7:124 http://respiratory-research.com/content/7/1/124
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The effect of GSNO treatment (60 μM for 4 hours) on the Cl- relative efflux rate measured in nasal epithelial cells with the  MQAE fluorescence method Figure 1
The effect of GSNO treatment (60 μM for 4 hours) on the Cl- relative efflux rate measured in nasal epithelial 
cells with the MQAE fluorescence method. Individual data from (a) CF patients and (b) healthy subjects; horizontal line 
indicates the mean. (c) Data are expressed as mean ± SEM and the number of subjects in each group is shown in the parenthe-
ses beside the legend. Significant difference from the control (paired Student's t-test) is indicated by asterisks (** p < 0.01).Respiratory Research 2006, 7:124 http://respiratory-research.com/content/7/1/124
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no significant effect of the cellular chloride or potassium
concentration in CFSME cells. Treatment with GSNO (4 h,
60 μM) caused a significant decrease of the cellular chlo-
ride concentration, and the decrease for chloride was
small but significant in the presence of IBMX and forsko-
lin (Fig. 4).
In the CFBE cells, 60 μM GSNO had no visible effect on
[Ca2+]i. The effect of 100 μM ATP was a robust elevation
in [Ca2+]i which in the cells previously exposed to GSNO
took longer time to return to the baseline values com-
pared to control cells (Fig. 5). Measurement of the area-
under-the curve indicates that the total amount of Ca2+
released into the cytoplasm by the ATP exposure was
increased by 15% in the case of GSNO pre-treatment (not
significant).
Discussion
Here, we have shown that GSNO increases cAMP-depend-
ent chloride efflux in primary nasal epithelial cells
obtained from delF508 homozygous CF patients. As such,
it has the potential to represent a corrector therapy for CF.
Strikingly, GSNO is an endogenous compound with
effects (and therapeutic uses) in several different organ
systems. Moreover, GSNO has several different airway
effects, and its levels are low in the CF airway; CF and
other airways diseases may therefore represent, at least in
part, GSNO deficiencies. Additionally, we have 1) con-
firmed using a monoclonal antibody that GSNO increases
maturation of delF508 CFTR in a delF508-homozygous
airway epithelial cells line; 2) confirmed that GSNO
increases the cAMP-stimulated chloride efflux in different
human airway cell lines (CFBE, CFSME) expressing
delF508 CFTR by using two independent techniques – the
MQAE video-imaging assay and X-ray microanalysis; 3)
further characterized the chloride efflux upregulated by
GSNO in delF508 CFTR homozygous cells, demonstrat-
ing that CFTR is involved; and 4) shown that GSNO does
not increase intracellular Ca2+ levels in CFBE cells.
CFTR-dependent Cl- secretion in homozygous CF patients
was found to be highly related to the respiratory status in
patients with CF with class I and II mutations, and it has
been demonstrated that even residual CFTR activity was a
good prognostic factor for pulmonary status in this subset
of patients [19]. We studied the effect of GSNO on chlo-
ride transport in nasal TCC from homozygous delF508 CF
patients. The delF508 mutation belongs to class II, which
is the class of abnormal protein folding mutations. Chlo-
ride efflux mediated by CFTR was, as expected, nonexist-
ent in TCC obtained from CF patients, since these cells
lack functional CFTR at the plasma membrane. Treatment
of these cells with GSNO for 4 h was able to restore CFTR-
mediated chloride transport to a level comparable with
the one observed in healthy TCC (Fig. 1).
Due to the scarcity of cells in the nasal brushing biopsy, a
direct test of GSNO effect on delF508 CFTR maturation
(immunoblot) was not possible in the primary cells.
However, in the bronchial cell line CFBE, homozygous for
delF508 CFTR, low μM concentrations of GSNO resulted
in a dose-dependent increase in the expression of both
bands B and C of the immunoblot. These low μM levels of
GSNO appear to affect CFTR primarily through a post-
transcriptional mechanism, although there appears also
Immunoblot analysis on homozygous ΔF508 CFBE cultured cells treated with various concentrations of GSNO Figure 2
Immunoblot analysis on homozygous ΔF508 CFBE cultured cells treated with various concentrations of 
GSNO. Western blot analysis of CFTR was performed on whole cell extracts from CFBE cells using the monoclonal antibody 
596, in the absence or presence of GSNO at different concentrations for 4 hours. Lane 1-control; lane 2- 0.5 μM; lane 3- 5 μM; 
and lane 4- 10 μM of GSNO. 50 μg of protein was loaded to each line.
C
B
GSNO (μ μ μ μM)   C     0.5     5      10     
C
B
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to be a modest, transcriptional effect through augmenta-
tion Sp3 transcription factor expression and binding [11].
Further, we attempted to characterize the channels
involved in Cl- transport using two CF cultured cells mod-
els, the CFBE41o- and CFSMEo- cell lines. In CFBE cells,
which are homozygous for the delF508 mutation, GSNO
treatment resulted in about a tripling of the rate of Cl-
efflux both under basal and cAMP-stimulated conditions.
A specific blocker of CFTR (CFTRinh-172) eliminated more
than 50 % of the increased Cl- transport while both GSNO
and cAMP agents were present, thus providing evidence of
the contribution of CFTR to the observed Cl- efflux. In
basal conditions, due to inherent phosphorylation, 60%
of wt-CFTR is in activated (open) state. Addition of cAMP
increases this state to 100% in wt-CFTR expressing
cells[20]. GSNO treatment might result in full activation
of CFTR, such that application of cAMP agonists would
not increase further the Cl- efflux. It is known that oxidiz-
ing conditions slow down CFTR gating while reducing
conditions increase open probability [21]. Since GSNO or
its products can interact with the cysteine residues of
CFTR, modification of gating cannot be excluded. In addi-
tion, the CFTRinh-172 is considered a specific blocker and
in recent years is widely used to prove the contribution of
CFTR. However, a blocker of Cl- channels other than CFTR
(H2DIDS) also resulted in an inhibition of the efflux,
either after GSNO treatment or without such treatment. In
the presence of cAMP stimulators a smaller proportion of
the Cl- efflux was blocked by non-specific H2DIDS com-
pared to the efflux under basal conditions (no cAMP ele-
vating agents present). This implies involvement of CFTR
as well as that of other Cl- channels to GSNO-induced
increase in Cl- efflux. Besides CFTR, Cl--conductive path-
ways in bronchial epithelial cells are Ca2+-activated and
volume-dependent Cl--channels. However, Ca2+-activated
channels are not likely to be directly responsible for the
efflux since the intracellular Ca2+ concentration remained
constant after GSNO application (Fig. 5). Volume
dependent Cl- channels were not investigated in the cur-
rent protocol.
The CFSME cells have been shown to produce vestigial
amounts of CFTR-mRNA, do not express detectable CFTR
protein, and characteristically lack cAMP-induced Cl- cur-
rents [22]. We documented Cl- loss after GSNO treatment
in CFSME cells by X-ray microanalysis and confirmed this
finding by Cl- efflux measurements using the MQAE fluo-
rescent dye method. In comparison with CFBE cells, Cl-
efflux in CFSME cells increased to lesser degree after
GSNO treatment, which could be due to the fact that these
cells are heterozygous for delF508 mutation (delF508/
2QX genotype).
Unlike in submucosal airway cell expressing wild-type
CFTR (Calu-3) [23] and cerebellar granular cells[24], in
CFBE cells there was no elevation in intracellular calcium
level after GSNO application. However, we observed an
increased area-under-the-curve after ATP exposure subse-
quent to GSNO treatment. This finding most likely is due
to delayed extrusion of Ca2+ from the cytoplasm, which is
dependent on the function of either the smooth endoplas-
mic reticulum Ca-ATPase or the plasma membrane Ca2+
pump. Both are known to be sensitive to oxidation of
their thiol groups and free radicals like peroxynitrite,
which is one of the possible breakdown products of
GSNO.
The effect of GSNO and GEA in CFBE (A) and CFSME (B)  cells on the Cl- efflux rate Figure 3
The effect of GSNO and GEA in CFBE (A) and 
CFSME (B) cells on the Cl-efflux rate. Cells were 
treated with 60 μM GSNO for 4 hours or 25 μM GEA for 
the indicated time, then the Cl- efflux rate was measured 
with the fluorescent indicator MQAE. "J basal": the basal 
efflux rate (recorded during exposure to Cl--free SR without 
agonists). "J cAMP": the cAMP-stimulated efflux rate 
(recorded during exposure to Cl--free SR containing 20 μM 
forskolin and 100 μM IBMX). For some experiments, during 
the basal efflux 400 μM DIDS was used to block Cl- channels 
(different from CFTR), while the CFTR specific inhibitor 
CFTRinh-172 (40 μM) was used during the cAMP-stimulated 
efflux. Data are expressed as mean ± SEM and the number of 
experiments in each group is shown in each column. Signifi-
cant difference from the control (ANOVA) is indicated by 
asterisks (* p < 0.05, ** p < 0.01).Respiratory Research 2006, 7:124 http://respiratory-research.com/content/7/1/124
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This paper for the first time demonstrates a GSNO-
induced increased Cl- efflux from native CF-airway epithe-
lial cells carrying the delF508 mutation. Both the func-
tional studies and the Western blot experiments support
the notion that GSNO in some way helps to overcome the
trafficking defect of delF508-CFTR. On the other hand,
GSNO does not promote Cl- efflux in airway epithelial
cells from healthy persons, which may speak against a
direct effect of GSNO on CFTR. In terms of a mechanism
by which GSNO induces chloride efflux from cells carry-
ing the delF508 mutation, GSNO has recently been
reported to act via both NO-cGMP dependent and inde-
pendent pathways[25]. We therefore compared Cl- efflux
in CFBE cells after GSNO treatment with the effect of a
lipophilic NO donor GEA3162, and the slight increase in
basal and cAMP-stimulated Cl- efflux caused by GEA3162
may support the notion that the effect of GSNO might to
a minor extent be due to NO radical release. However, the
mechanism by which GSNO acts is certainly more com-
plex and may well be multifactorial, including effects at
the nuclear level [11]. Nevertheless, the fact that GSNO is
able to normalize Cl- efflux from CF airway epithelial
cells, in combination with the fact that GSNO is a natu-
rally occurring, non-toxic compound, supports further
study of this compound as a potential drug for CF.
Conclusion
We have shown that treatment with GSNO normalizes Cl-
efflux from cells isolated from CF patients with the
delF508-mutation; and 2) associated increase in Cl- efflux
found was in part due to CFTR maturation from respira-
tory epithelial cell lines with the delF508-CFTR mutation.
This endogenous compound hence may be of value as a
possible candidate to correct the basic defect in CF.
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The effect of GSNO on intracellular ion composition in  CFSME cells assessed by X-ray microanalysis method Figure 4
The effect of GSNO on intracellular ion composition 
in CFSME cells assessed by X-ray microanalysis 
method. "Control": Cells kept 2 min in Cl--free SR. "GSNO": 
cells treated with 60 μM GSNO for 4 hours, then exposed 
for 3 min to Cl--free SR. fors+IBMX = 3 min exposure to Cl--
free SR containing 20 μM forskolin and 100 μM IBMX. Data 
are expressed as mean ± SEM. Significant difference from the 
control (ANOVA) is indicated by asterisks (* p < 0.05, ** p < 
0.01).
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